Rocket Pharmaceuticals (RCKT) PT Raised to $60 at Piper Sandler After Positive POC Data
Tweet Send to a Friend
Piper Sandler analyst Tyler Van Buren raised the price target on Rocket Pharmaceuticals (NASDAQ: RCKT) to $60.00 (from $50.00) after ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
